Wild-type p53 induced sensitization of mutant p53 TNF-resistant cells:: Role of caspase-8 and mitochondria

被引:21
作者
Ameyar-Zazoua, M
Larochette, N
Dorothée, G
Daugas, E
Haddada, H
Gouloumet, V
Métivier, D
Stancou, R
Mami-Chouaib, F
Kroemer, G
Chouaib, S
机构
[1] Inst Gustave Roussy, INSERM U487, Lab Cytokines & Immunol Tumeurs Humaines, F-94805 Villejuif, France
[2] Inst Gustave Roussy, CNRS UMR1599, F-94805 Villejuif, France
[3] Inst Gustave Roussy, INSERM U362, F-94805 Villejuif, France
关键词
p53; TNF; mitochondria; caspase-8;
D O I
10.1038/sj.cgt.7700434
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
In the present study, we have investigated the mechanisms by which the restoration of wild-type (wt) p53 functions in p53 mutant cells increases their susceptibility to the cytotoxic action of tumor necrosis factor (TNF). Our data indicate that the resistance of p53-mutated cl.1001 cells to TNF-induced cell death was not due to a defect in the expression of TRADD and FADD, yet correlated with a reduced caspase-8 activation as well as a deficient mitochondrial membrane permeabilization. Moreover, cl.1001 cells failed to translocate the mitochondrial AIF and cytochrome c to the nucleus and to the cytosol, respectively, in response to TNF. Sensitization of these cells, following infection with a recombinant adenovirus encoding wtp53, to TNF-induced cytotoxicity resulted in the restoration of caspase-8 cleavage and the reestablishment of mitochondrial signs of apoptosis. These findings suggest that the crosstalk between p53 and TNF-induced cell death depends on mitochondria and that the combination of TNF and Adwtp53 may be a potential strategy to sensitize mutant p53 TNF-resistant tumors to the cytotoxic action of this cytokine.
引用
收藏
页码:219 / 227
页数:9
相关论文
共 50 条
[31]   Therapeutic potential of recombinant p53 overexpression in breast cancer cells expressing endogenous wild-type p53 [J].
Li, PX ;
Bui, T ;
Gray, D ;
Klamut, HJ .
BREAST CANCER RESEARCH AND TREATMENT, 1998, 48 (03) :273-286
[32]   Therapeutic potential of recombinant p53 overexpression in breast cancer cells expressing endogenous wild-type p53 [J].
Peixiang Li ;
Thuy Bui ;
Dawn Gray ;
Henry J. Klamut .
Breast Cancer Research and Treatment, 1998, 48 :273-286
[33]   Aging-associated truncated form of p53 interacts with wild-type p53 and alters p53 stability, localization, and activity [J].
Moore, Lynette ;
Lu, Xiongbin ;
Ghebranious, Nader ;
Tyner, Stuart ;
Donehower, Lawrence A. .
MECHANISMS OF AGEING AND DEVELOPMENT, 2007, 128 (11-12) :717-730
[34]   MicroRNAs, wild-type and mutant p53 More questions than answers [J].
Jones, Matthew Fletcher ;
Lal, Ashish .
RNA BIOLOGY, 2012, 9 (06) :781-791
[35]   TRANSCRIPTIONAL REPRESSION IN NORMAL HUMAN KERATINOCYTES BY WILD-TYPE AND MUTANT P53 [J].
ALVAREZSALAS, LM ;
VELAZQUEZ, A ;
LOPEZBAYGHEN, E ;
WOODWORTH, CD ;
GARRIDO, E ;
GARIGLIO, P ;
DIPAOLO, JA .
CANCER LETTERS, 1995, 91 (01) :85-92
[36]   Advanced Strategies for Therapeutic Targeting of Wild-Type and Mutant p53 in Cancer [J].
Zhang, Shengliang ;
Carlsen, Lindsey ;
Hernandez Borrero, Liz ;
Seyhan, Attila A. ;
Tian, Xiaobing ;
El-Deiry, Wafik S. .
BIOMOLECULES, 2022, 12 (04)
[37]   A mutant P53 can activate apoptosis through a mechanism distinct from those induced by wild type P53 [J].
He, M ;
Rennie, PS ;
Dragowska, V ;
Nelson, CC ;
Jia, W .
FEBS LETTERS, 2002, 517 (1-3) :151-154
[38]   Wild-type p53 activates SAP expression in lymphoid cells [J].
N Nagy ;
M Takahara ;
J Nishikawa ;
J C Bourdon ;
L L Kis ;
G Klein ;
E Klein .
Oncogene, 2004, 23 :8563-8570
[39]   Wild-type p53 activates SAP expression in lymphoid cells [J].
Nagy, N ;
Takahara, M ;
Nishikawa, J ;
Bourdon, JC ;
Kis, LL ;
Klein, G ;
Klein, E .
ONCOGENE, 2004, 23 (53) :8563-8570
[40]   Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation [J].
Venkatachalam, S ;
Shi, YP ;
Jones, SN ;
Vogel, H ;
Bradley, A ;
Pinkel, D ;
Donehower, LA .
EMBO JOURNAL, 1998, 17 (16) :4657-4667